World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
68
Citations
16671
World Ranking
2589
National Ranking
104

Riccardo Dolcetti publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Riccardo Dolcetti sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 368 publications — 76th percentile

76% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Riccardo Dolcetti D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Riccardo Dolcetti sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 68 D-Index — 49th percentile

49% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Riccardo Dolcetti is affiliated with the University of Queensland in Australia. Their primary research focus spans several areas within medicine, immunology, and molecular biology. They have contributed notably to the fields of immunotherapy, cancer research, and genetic studies, with particular emphasis on immune responses and cancer immunotherapy mechanisms.

The number of publications authored by Riccardo Dolcetti in various fields highlight their multidisciplinary expertise. Key fields of study include:

  • Medicine
  • Immunology and Microbiology
  • Biochemistry, Genetics and Molecular Biology

Their work extends into subfields that cover:
  • Immunology
  • Oncology
  • Molecular Biology
  • Pathology and Forensic Medicine
  • Genetics

Main topics of research focus on:
  • Immunotherapy and Immune Responses
  • Cancer Immunotherapy and Biomarkers
  • Immune Cell Function and Interaction
  • CAR-T cell therapy research
  • Lymphoma Diagnosis and Treatment
  • Immune cells in cancer
  • Viral-associated cancers and disorders

Riccardo Dolcetti has published several papers in notable scientific journals, emphasizing immunotherapy and cancer research. Recent publications include:

  • Endocytosis Inhibition in Humans to Improve Responses to ADCC-Mediating Antibodies, 2020, Cell
  • Enhancing chimeric antigen receptor T-cell immunotherapy against cancer using a nanoemulsion-based vaccine targeting cross-presenting dendritic cells, 2020, Clinical & Translational Immunology
  • Targeting Tumor Heterogeneity with Neoantigen-Based Cancer Vaccines, 2023, Cancer Research
  • Weaponizing natural killer cells for solid cancer immunotherapy, 2022, Trends in cancer
  • Reprogramming the anti-tumor immune response via CRISPR genetic and epigenetic editing, 2021, Molecular Therapy - Methods & Clinical Development

Frequent publication venues for Riccardo Dolcetti's work include:

  • Cancer Research
  • Cancers
  • Frontiers in Immunology
  • Frontiers in Oncology
  • Hemato

Co-authorship is a significant element in Riccardo Dolcetti's research activities. Frequent collaborators include:

  • Roberta Mazzieri
  • Bijun Zeng
  • Agostino Steffan
  • Davide Moi
  • Liz Kenny

Riccardo Dolcetti's contributions intersect immunology, oncology, and molecular biology with a focus on innovative immunotherapeutic strategies and immune system modulation in cancer treatment contexts.

Best Publications

  • Evidence for an Association Between Chlamydia psittaci and Ocular Adnexal Lymphomas

    Andrés J. M. Ferreri;Massimo Guidoboni;Maurilio Ponzoni;Carlo De Conciliis

  • High prevalence of activated intraepithelial cytotoxic T lymphocytes and increased neoplastic cell apoptosis in colorectal carcinomas with microsatellite instability.

    Riccardo Dolcetti;Alessandra Viel;Claudio Doglioni;Antonio Russo

  • Microsatellite Instability and High Content of Activated Cytotoxic Lymphocytes Identify Colon Cancer Patients with a Favorable Prognosis

    Massimo Guidoboni;Roberta Gafà;Alessandra Viel;Claudio Doglioni

  • HLA-A11 epitope loss isolates of Epstein-Barr virus from a highly A11+ population.

    PO de Campos-Lima;R Gavioli;QJ Zhang;LE Wallace

  • Characterization of Overt B-Cell Lymphomas in Patients With Hepatitis C Virus Infection

    Salvatore De Vita;Cosimo Sacco;Domenico Sansonno;Annunziata Gloghini

  • Hodgkin's disease and human immunodeficiency virus infection: clinicopathologic and virologic features of 114 patients from the Italian Cooperative Group on AIDS and Tumors.

    Umberto Tirelli;Domenico Errante;Riccardo Dolcetti;Annunziata Gloghini

  • High frequency of p53 gene alterations associated with protein overexpression in human squamous cell carcinoma of the larynx.

    R Maestro;R Dolcetti;D Gasparotto;C Doglioni

  • Regression of Ocular Adnexal Lymphoma After Chlamydia Psittaci–Eradicating Antibiotic Therapy

    Andrés J M Ferreri;Maurilio Ponzoni;Massimo Guidoboni;Carlo De Conciliis

  • Bacteria-Eradicating Therapy With Doxycycline in Ocular Adnexal MALT Lymphoma: A Multicenter Prospective Trial

    Andrés J. M. Ferreri;Maurilio Ponzoni;Massimo Guidoboni;Antonio Giordano Resti

  • Hepatitis C virus within a malignant lymphoma lesion in the course of type II mixed cryoglobulinemia

    S. De Vita;D. Sansonno;R. Dolcetti;G. Ferraccioli

  • Chlamydophila Psittaci Eradication With Doxycycline As First-Line Targeted Therapy for Ocular Adnexae Lymphoma: Final Results of an International Phase II Trial

    Andrés J M Ferreri;Silvia Govi;Elisa Pasini;Silvia Mappa

  • Multiple HLA A11-restricted cytotoxic T-lymphocyte epitopes of different immunogenicities in the Epstein-Barr virus-encoded nuclear antigen 4

    R Gavioli;M G Kurilla;P O de Campos-Lima;L E Wallace

  • p53 over-expression is an early event in the development of human squamous-cell carcinoma of the larynx: Genetic and prognostic implications

    Riccardo Dolcetti;Claudio Doglioni;Roberta Maestro;Daniela Gasparotto

  • Plasticity of Type I Interferon-Mediated Responses in Cancer Therapy: From Anti-tumor Immunity to Resistance.

    Megha Budhwani;Roberta Mazzieri;Riccardo Dolcetti

  • Local suppression of Epstein-Barr virus (EBV)-specific cytotoxicity in biopsies of EBV-positive Hodgkin's disease

    T Frisan;J Sjoberg;R Dolcetti;M Boiocchi

  • The Epstein-Barr virus latent membrane protein-1 (LMP1) induces interleukin-10 production in Burkitt lymphoma lines.

    Hiroshi Nakagomi;Riccardo Dolcetti;Maria Teresa Bejarano;Pavel Pisa

  • Endocytosis Inhibition in Humans to Improve Responses to ADCC-Mediating Antibodies

    Hui Yi Chew;Priscila O. De Lima;Jazmina L. Gonzalez Cruz;Blerida Banushi

  • Virologic and immunologic evidence supporting an association between HHV-6 and Hashimoto's thyroiditis.

    Elisabetta Caselli;Maria Chiara Zatelli;Roberta Rizzo;Sabrina Benedetti

  • HUMAN HERPESVIRUSES 6 AND 7 IN SALIVARY-GLANDS AND SHEDDING IN SALIVA OF HEALTHY AND HUMAN-IMMUNODEFICIENCY-VIRUS POSITIVE INDIVIDUALS

    D Di Luca;P Mirandola;T Ravaioli;R Dolcetti

  • Post-transplant lymphoproliferative disorders: from epidemiology to pathogenesis-driven treatment.

    Maria Raffaella Petrara;Silvia Giunco;Diego Serraino;Riccardo Dolcetti

Frequent Co-Authors

Claudio Doglioni
Claudio Doglioni Vita-Salute San Raffaele University
Annunziata Gloghini
Annunziata Gloghini University of Milan
Antonino Carbone
Antonino Carbone Centro di Riferimento Oncologico
Andrés J.M. Ferreri
Andrés J.M. Ferreri Vita-Salute San Raffaele University
Maurilio Ponzoni
Maurilio Ponzoni Vita-Salute San Raffaele University
Alessandra Viel
Alessandra Viel Centro di Riferimento Oncologico
Roberta Maestro
Roberta Maestro Centro di Riferimento Oncologico
Gianfranco Ferraccioli
Gianfranco Ferraccioli Catholic University of the Sacred Heart
Umberto Tirelli
Umberto Tirelli National Institutes of Health

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in expanding their expertise beyond Immunology, pursuing advanced nursing degrees presents a valuable option. Many students explore easiest np programs to get into to find accessible pathways that balance rigorous academics with flexible admissions criteria. This approach can accelerate career advancement without compromising educational quality.

Specializing further, online psychiatric mental health nurse practitioner programs (PMHNP) offer focused clinical training crucial for addressing behavioral health needs. Prospective students often seek online pmhnp programs with clinical placement to ensure hands-on experience that bridges theory and practice effectively.

Affordability also plays a critical role, especially for those balancing education with other responsibilities. Exploring the cheapest online pmhnp programs can help minimize financial strain without sacrificing program quality or learning outcomes.

Finally, understanding the financial prospects after graduation is essential. Detailed insights into the dnp salary across various states can guide students in making informed decisions about investing in advanced degrees and choosing relocation options to maximize earning potential.

Best Scientists Citing Riccardo Dolcetti

Trending Scientists

Recently Published Articles